DKK1 and neoplasm: Taken together, these results suggest that confluent BM-MSCs predominantly exert anti-tumorigenic activity, which might be mediated by the secretion of DKK-1 and/or TRAIL, previoulsy shown to inhibit Wnt signaling, block tumor growth, and induce apoptosis in a variety of tumor cells [12,13,14].